home / stock / clsd / clsd articles

CLSD Articles, Clearside Biomedical Inc.

Stock Information
Company Name: Clearside Biomedical Inc.
Stock Symbol: CLSD
Market: NASDAQ
Website: clearsidebio.com
Menu
CLSD CLSD Quote CLSD Short CLSD News CLSD Articles CLSD Message Board
Get CLSD Alerts

News, Short Squeeze, Breakout and More Instantly...
Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery | Benzinga

- Webinar to be held on Wednesday, July 24, 2024 at 8:00 am ET - - Retina Specialists to Provide Insights and Real-World Experience with Suprachor...
Why Is Clearside Biomedical Stock Gaining Today? | Benzinga

Oppenheimer initiated coverage on Clearside Biomedical Inc (NASDAQ:CLSD), a biopharmaceutical company focused on delivering therapies to the back o...

Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA® | Benzinga

- Expert Panel of Ophthalmologists Developed Professional Guidelines in Using the Innovative Technique for Retinal Therapeutic Delivery - - Curren...

Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying | Benzinga

The Dow Jones index closed higher by around 350 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concer...
Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference | Benzinga

ALPHARETTA, Ga., May 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the del...

Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 | Benzinga

ALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the d...

Expensify And 2 Other Stocks Under $2 Insiders Are Buying | Benzinga

The Dow Jones index closed higher by over 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern aro...
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors | Benzinga

ALPHARETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the d...

Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference | Benzinga

ALPHARETTA, Ga., April 02, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the d...

Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer | Benzinga

ALPHARETTA, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the d...
Next 10